Willow Biosciences Inc.

TSX (CAD): Willow Biosciences Inc. (WLLW)

Last Price

0.04

Today's Change

-0.04 (50.00%)

Day's Change

0.035 - 0.06

Trading Volume

4,760,587

Profile
WLLW

Exchange:  Toronto Stock Exchange Toronto Stock Exchange

Currency:  CAD CAD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Dr. Chris Savile Dr. Chris Savile

Full Time Employees:  19 19

IPO Date:  2021-02-11 2021-02-11

CIK: 

ISIN:  CA97111B4047 CA97111B4047

CUSIP:  97111B404 97111B404

Beta:  1.14 1.14

Last Dividend:  0.00 0.00

Dcf Diff:  0.00 0.00

Dcf:  0.00 0.00

Description

Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical product industries in Canada. The company also produces cannabidiol, cannabigerol, and varin cannabinoids, such as cannabigerovarin, cannabidivarin, and tetrahydrocannabivarin. Willow Biosciences Inc. was incorporated in 1981 and is headquartered in Calgary, Canada.

Address

202, 1201-5th Street SW,
Calgary, AB T2R 0Y6, CA

403 910 5140

http://www.willowbio.com

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment